Suitability of Bupropion SR for nicotine-dependent smokers: Problems in a practice setting
No Thumbnail Available
Authors
Kohlenberg, Barbara S.
Antonuccio, David O.
Hayes, Steven C.
Gifford, Elizabeth V.
Piasecki, Melissa P.
Issue Date
2004
Type
Citation
Language
Keywords
bupropion sr , contraindications , nicotine dependence , smoking cessation
Alternative Title
Abstract
Background: Bupropion SR ( Zyban) has been shown in randomized controlled trials to be an efficacious pharmacological aid for smoking cessation; however, recent reports have raised serious concerns about the breadth of its applicability without complications or contraindications. Methods: We examined this issue in a well-documented medical population, i.e. veterans volunteering to participate in a smoking cessation treatment research program involving the use of bupropion SR. Results: Overall, 22% of the 78 subjects who met the study criteria were appropriate for and completed the course of medication. Conclusions: Thus, bupropion SR in nicotine-dependent veterans may not be broadly applicable when conservative prescribing guidelines are carefully followed. Copyright (C) 2004 S. Karger AG, Basel.
Description
Citation
Publisher
License
In Copyright
Journal
Volume
Issue
PubMed ID
ISSN
0033-3190